Quoin Pharmaceuticals Ltd...

NASDAQ: QNRX · Real-Time Price · USD
8.90
-0.07 (-0.78%)
At close: Jun 04, 2025, 3:59 PM
8.83
-0.79%
After-hours: Jun 04, 2025, 07:20 PM EDT

Quoin Pharmaceuticals Statistics

Share Statistics

Quoin Pharmaceuticals has 588.17K shares outstanding. The number of shares has increased by 135.73% in one year.

Shares Outstanding 588.17K
Shares Change (YoY) 135.73%
Shares Change (QoQ) 77.2%
Owned by Institutions (%) 0.03%
Shares Floating n/a
Failed to Deliver (FTD) Shares 296
FTD / Avg. Volume 0.1%

Short Selling Information

The latest short interest is 225.36K, so 38.32% of the outstanding shares have been sold short.

Short Interest 225.36K
Short % of Shares Out 38.32%
Short % of Float 1.18%
Short Ratio (days to cover) 1

Valuation Ratios

PE Ratio 0
Forward PE -0.63
PS Ratio 0
Forward PS 0.1
PB Ratio 0
P/FCF Ratio -0.01
PEG Ratio 0
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Quoin Pharmaceuticals.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 3.57, with a Debt / Equity ratio of 0.

Current Ratio 3.57
Quick Ratio 3.57
Debt / Equity 0
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage 0

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee n/a
Profits Per Employee $-2,987,490,666.67
Employee Count 3
Asset Turnover 0
Inventory Turnover n/a

Taxes

Income Tax -8.95B
Effective Tax Rate 99.9%

Stock Price Statistics

The stock price has increased by 1114.1% in the last 52 weeks. The beta is 1.78, so Quoin Pharmaceuticals's price volatility has been higher than the market average.

Beta 1.78
52-Week Price Change 1114.1%
50-Day Moving Average 7.48
200-Day Moving Average 2.79
Relative Strength Index (RSI) 61.84
Average Volume (20 Days) 287,378

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -9.57M
Net Income -8.96B
EBITDA -8.9M
EBIT -9.01M
Earnings Per Share (EPS) -1911.5
Full Income Statement

Balance Sheet

The company has 3.62M in cash and 0 in debt, giving a net cash position of 3.62M.

Cash & Cash Equivalents 3.62M
Total Debt n/a
Net Cash n/a
Retained Earnings -55.17B
Total Assets 12.96M
Working Capital 7.64M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -7.89M and capital expenditures 0, giving a free cash flow of -7.86M.

Operating Cash Flow -7.89M
Capital Expenditures n/a
Free Cash Flow -7.86M
FCF Per Share -58.65
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

QNRX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for QNRX is $4, which is -54.3% lower than the current price. The consensus rating is "Buy".

Price Target $4
Price Target Difference -54.3%
Analyst Consensus Buy
Analyst Count 1
Stock Forecasts

Stock Splits

The last stock split was on Jul 18, 2023. It was a backward split with a ratio of 1:12.

Last Split Date Jul 18, 2023
Split Type backward
Split Ratio 1:12

Scores

Altman Z-Score -7.01
Piotroski F-Score 3